Nisa Investment Advisors
ALLO icon

Nisa Investment Advisors’s Allogene Therapeutics ALLO Stock Holding History

Nisa Investment Advisors’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14K Hold
1,028
– – ﹤0.01% 2741
2026
Q1 		$2.51K Hold
1,028
– – ﹤0.01% 2583
2025
Q4 		$1.41K Sell
1,028
-2,450
-70% -$3.23K ﹤0.01% 2662
2025
Q3 		$4.31K Buy
3,478
+866
+33% +$1.03K ﹤0.01% 2464
2025
Q2 		$2.95K Sell
2,612
-673
-20% -$894 ﹤0.01% 2532
2025
Q1 		$4.8K Buy
3,285
+364
+12% +$686 ﹤0.01% 2266
2024
Q4 		$6.22K Sell
2,921
-7,869
-73% -$19.4K ﹤0.01% 2230
2024
Q3 		$30.2K Buy
10,790
+23
+0.2% +$61 ﹤0.01% 1777
2024
Q2 		$25.1K Buy
10,767
+8,734
+430% +$25.8K ﹤0.01% 1865
2024
Q1 		$9.09K Buy
2,033
+13
+0.6% +$54 ﹤0.01% 2057
2023
Q4 		$6.48K Sell
2,020
-80
-4% -$227 ﹤0.01% 2097
2023
Q3 		$6.66K Buy
2,100
+140
+7% +$614 ﹤0.01% 2248
2023
Q2 		$9.74K Buy
1,960
+1,400
+250% +$7.57K ﹤0.01% 2260
2023
Q1 		$3K Hold
560
– – ﹤0.01% 2272
2022
Q4 		$4K Sell
560
-68
-11% -$630 ﹤0.01% 2304
2022
Q3 		$6K Buy
628
+68
+12% +$924 ﹤0.01% 2262
2022
Q2 		$6K Hold
560
– – ﹤0.01% 2248
2022
Q1 		$5K Buy
+560
New +$5.83K ﹤0.01% 2304
2021
Q4 		– Sell
-560
Closed -$14K – 2173
2021
Q3 		$14K Hold
560
– – ﹤0.01% 2156
2021
Q2 		$15K Hold
560
– – ﹤0.01% 2171
2021
Q1 		$20K Hold
560
– – ﹤0.01% 2126
2020
Q4 		$14K Sell
560
-1,250
-69% -$40.7K ﹤0.01% 2170
2020
Q3 		$68K Buy
1,810
+1,350
+293% +$50.9K ﹤0.01% 1669
2020
Q2 		$20K Buy
+460
New +$16.6K ﹤0.01% 1772

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nisa Investment Advisors's ALLO Position: Q2 2026 in Review

Nisa Investment Advisors held its Allogene Therapeutics (ALLO) position steady in Q2 2026 at 1,028 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2741.

Nisa Investment Advisors first reported a position in ALLO in Q2 2020 and has held it in 24 quarters since. The position peaked at $68K in Q3 2020. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Nisa Investment Advisors held 1,028 shares of Allogene Therapeutics worth $2.14K as of Q2 2026.
  • Nisa Investment Advisors left its Allogene Therapeutics share count unchanged in Q2 2026.
  • Allogene Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2741 holding.
  • Nisa Investment Advisors first reported a position in Allogene Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Nisa Investment Advisors's Allogene Therapeutics position peaked at $68K in Q3 2020.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.